Metropolis Healthcare Share Price Target For Tomorrow, Next Week & Next Month
Metropolis Healthcare Limited | |||
 | Price: ₹1,995.00 (+0.11%) | ||
| 52 Week Low: ₹1,315.00 52 Week High: ₹2,318.30 | |||
| Market Capital: 10,373.68 Crore (Midcap) | |||
| Healthcare -> Diagnostics & Research | |||
Metropolis Healthcare Stock Comparison: Metropolis Healthcare vs Vijaya Diagnostic Centre | Metropolis Healthcare vs Thyrocare Technologies | Metropolis Healthcare vs Krsnaa Diagnostics | Metropolis Healthcare vs Jupiter Life Line Hospitals Limited | Metropolis Healthcare vs Blue Jet Healthcare | Metropolis Healthcare vs Wockhardt | |||
Share Price HistoryMETROPOLIS FinancialsTomorrow TargetYearly TargetsDividend HistoryNo BonusNo Split
Show Table of Contents
Metropolis Healthcare Recent Performance
Over the past 476 trading days, the value of Metropolis Healthcare's stock has gained ₹475.65 (+31.31%). On 07 Nov 2023, one share was worth ₹1519.35 and by 10 Oct 2025, the value jumped to ₹1995.00. During this period it created a highest high of ₹2318.30 and lowest low of ₹1315.00.
Metropolis Healthcare Share Price Target - Tomorrow
| Level | Value | Analysis |
|---|---|---|
| Tomorrow Target 3 | 2147.1 (+7.62%) | Price Action: 29 Aug 2025 Low |
| Tomorrow Target 2 | 2125 (+6.51%) | Price Action: 20 Aug 2025 Low |
| Tomorrow Target 1 | 2101.5 (+5.33%) | Price Action: 14 Aug 2025 Low |
| Current Price | 1995.00 | Metropolis Healthcare's share price as of 10 Oct 2025 |
| Stop Loss 1 | 1892.3 (-5.15%) | Price Action: 14 Jul 2025 High |
| Stop Loss 2 | 1866.6 (-6.44%) | Price Action: 09 Jul 2025 Low |
| Stop Loss 3 | 1844.02 (-7.57%) | Technical Indicator: MA200 |
Summary
10 Oct 2025: Metropolis Healthcare finished the day at ₹1995.00, gaining ₹2.20 (+0.11%) in 1 day.
Our analysis for tomorrow predicts a potential movement of -7.57% to 7.62% with:
- Target prices: ₹2101.5 to ₹2147.1
- Support levels: ₹1892.3 to ₹1844.02
- Recent high: ₹2019.50
- Recent low: ₹1990.10
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Metropolis Healthcare Share Price Target - Next Week
| Level | Value | Analysis |
|---|---|---|
| Next Week Target 3 | 2082.25 (+4.37%) | Price Action: Sep 2024 Low |
| Next Week Target 2 | 2060.9 (+3.3%) | Price Action: 06 Aug 2025 High |
| Next Week Target 1 | 2038.2 (+2.16%) | Price Action: 31 Jul 2025 High |
| Current Price | 1995.00 | Metropolis Healthcare's share price as of 10 Oct 2025 |
| Stop Loss 1 | 1981.3 (-0.69%) | Price Action: 31 Jul 2025 Low |
| Stop Loss 2 | 1960 (-1.76%) | Price Action: 18 Jul 2025 High |
| Stop Loss 3 | 1936.01 (-2.96%) | Technical Indicator: MA100 |
Weekly Target Summary
For next week, our analysis suggests a potential movement range of -2.96% to 4.37% with:
- Upper targets: ₹2038.2 to ₹2082.25
- Support levels: ₹1981.3 to ₹1936.01
Metropolis Healthcare Share Price Target - Next Month
| Level | Value | Analysis |
|---|---|---|
| Next Month Target 3 | 2169.7 (+8.75%) | Price Action: Aug 2024 High |
| Next Month Target 2 | 2147.1 (+7.62%) | Price Action: 29 Aug 2025 Low |
| Next Month Target 1 | 2122 (+6.36%) | Price Action: 11 Sep 2025 Low |
| Current Price | 1995.00 | Metropolis Healthcare's share price as of 10 Oct 2025 |
| Stop Loss 1 | 1960 (-1.76%) | Price Action: 18 Jul 2025 High |
| Stop Loss 2 | 1936.01 (-2.96%) | Technical Indicator: MA100 |
| Stop Loss 3 | 1915.9 (-3.97%) | Price Action: Sep 2025 Low |
Monthly Target Summary
Looking ahead to next month, technical analysis indicates:
- Potential price movement: -3.96% to 8.76% with:
- Target range: ₹2122 to ₹2169.7
- Support levels: ₹1960 to ₹1915.9
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
